Phosphorylated EIF2α Predicts Disease-free Survival in Triple-negative Breast Cancer Patients

Overview

Journal Sci Rep

Specialty Science

Date 2017 Mar 16

PMID 28294178

Citations 24

Authors

Liang Guo

Yayun Chi

Jingyan Xue

LinXiaoxi Ma

Zhiming Shao

Jiong Wu

Affiliations

Soon will be listed here.

Abstract

Phosphorylated eukaryotic translation initiation factor 2α (p-eIF2α), which functions as a marker of endoplasmic reticulum stress, has been reported to be associated with patient prognosis in various cancers. However, little is known about the prognostic value of p-eIF2α in breast cancer, particularly in different breast cancer subtypes. An immunohistochemistry screen for p-eIF2α was performed using a tissue microarray containing 233 tumors and paired peritumoral tissues from female patients diagnosed with breast cancer. The staining results were scored semiquantitatively, and the p-eIF2α expression level in breast cancer and its potential prognostic value were investigated. In this retrospective cohort study, we found that p-eIF2α levels were significantly upregulated in breast cancer (P < 0.001). p-eIF2α level was negatively correlated with lymph node status (P = 0.039). Survival analysis by Kaplan-Meier estimation and Cox regression showed that p-eIF2α level was correlated with better disease free survival (P = 0.026) and served as an independent prognostic factor (P = 0.046) in patients with triple-negative breast cancer. Our study revealed that p-eIF2α was upregulated in breast cancer and represented a novel predictor of prognosis in patients with triple-negative subtype.

Citing Articles

Maintenance of p-eIF2α levels by the eIF2B complex is vital for colorectal cancer.

Skapik I, Giacomelli C, Hahn S, Deinlein H, Gallant P, Diebold M EMBO J. 2025; .

PMID: 40016419 DOI: 10.1038/s44318-025-00381-9.

The clinical outcome, pathologic spectrum, and genomic landscape for 454 cases of salivary mucoepidermoid carcinoma.

Wang X, Bai J, Yan J, Li B NPJ Precis Oncol. 2024; 8(1):238.

PMID: 39438706 PMC: 11496733. DOI: 10.1038/s41698-024-00735-2.

Strategies for engineering oncolytic viruses to enhance cancer immunotherapy.

Yin Z, Wang Z Front Pharmacol. 2024; 15:1450203.

PMID: 39309012 PMC: 11413971. DOI: 10.3389/fphar.2024.1450203.

Novel chromium (III)-based compound for inhibition of oxaliplatin-resistant colorectal cancer progression.

Chen M, Devi H, Pien H, Wen S, Sheu J, Tsai B Am J Cancer Res. 2024; 14(3):979-995.

PMID: 38590406 PMC: 10998745. DOI: 10.62347/XTRT2780.

Inhibition of EIF2α Dephosphorylation Decreases Cell Viability and Synergizes with Standard-of-Care Chemotherapeutics in Head and Neck Squamous Cell Carcinoma.

Cyran A, Kleinegger F, Nass N, Naumann M, Haybaeck J, Arens C Cancers (Basel). 2023; 15(22).

PMID: 38001610 PMC: 10670742. DOI: 10.3390/cancers15225350.

References

Schwanhausser B, Busse D, Li N, Dittmar G, Schuchhardt J, Wolf J . Corrigendum: Global quantification of mammalian gene expression control. Nature. 2013; 495(7439):126-7. DOI: 10.1038/nature11848. View

Reimold A, Iwakoshi N, MANIS J, Vallabhajosyula P, Szomolanyi-Tsuda E, Gravallese E . Plasma cell differentiation requires the transcription factor XBP-1. Nature. 2001; 412(6844):300-7. DOI: 10.1038/35085509. View

Rosenwald I, Hutzler M, Wang S, Savas L, Fraire A . Expression of eukaryotic translation initiation factors 4E and 2alpha is increased frequently in bronchioloalveolar but not in squamous cell carcinomas of the lung. Cancer. 2001; 92(8):2164-71. DOI: 10.1002/1097-0142(20011015)92:8<2164::aid-cncr1559>3.0.co;2-a. View

Talloczy Z, Jiang W, Virgin 4th H, Leib D, Scheuner D, Kaufman R . Regulation of starvation- and virus-induced autophagy by the eIF2alpha kinase signaling pathway. Proc Natl Acad Sci U S A. 2002; 99(1):190-5. PMC: 117537. DOI: 10.1073/pnas.012485299. View

Wang M, Kaufman R . The impact of the endoplasmic reticulum protein-folding environment on cancer development. Nat Rev Cancer. 2014; 14(9):581-97. DOI: 10.1038/nrc3800. View

Lobo M, Martin M, Perez M, Alonso F, Redondo C, Alvarez M . Levels, phosphorylation status and cellular localization of translational factor eIF2 in gastrointestinal carcinomas. Histochem J. 2000; 32(3):139-50. DOI: 10.1023/a:1004091122351. View

Arai M, Kondoh N, Imazeki N, Hada A, Hatsuse K, Kimura F . Transformation-associated gene regulation by ATF6alpha during hepatocarcinogenesis. FEBS Lett. 2005; 580(1):184-90. DOI: 10.1016/j.febslet.2005.11.072. View

Hart L, Cunningham J, Datta T, Dey S, Tameire F, Lehman S . ER stress-mediated autophagy promotes Myc-dependent transformation and tumor growth. J Clin Invest. 2012; 122(12):4621-34. PMC: 3533536. DOI: 10.1172/JCI62973. View

Bchir W, Maurin A, Carraro V, Averous J, Jousse C, Muranishi Y . The eIF2α/ATF4 pathway is essential for stress-induced autophagy gene expression. Nucleic Acids Res. 2013; 41(16):7683-99. PMC: 3763548. DOI: 10.1093/nar/gkt563. View

10.

Ron D, Walter P . Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol. 2007; 8(7):519-29. DOI: 10.1038/nrm2199. View

11.

Zhang K, Wong H, Song B, Miller C, Scheuner D, Kaufman R . The unfolded protein response sensor IRE1alpha is required at 2 distinct steps in B cell lymphopoiesis. J Clin Invest. 2005; 115(2):268-81. PMC: 546421. DOI: 10.1172/JCI21848. View

12.

Aktas B, Qiao Y, Ozdelen E, Schubert R, Sevinc S, Harbinski F . Small-Molecule targeting of translation initiation for cancer therapy. Oncotarget. 2013; 4(10):1606-17. PMC: 3858549. DOI: 10.18632/oncotarget.1186. View

13.

Rosenwald I, Koifman L, Savas L, Chen J, Woda B, Kadin M . Expression of the translation initiation factors eIF-4E and eIF-2* is frequently increased in neoplastic cells of Hodgkin lymphoma. Hum Pathol. 2008; 39(6):910-6. DOI: 10.1016/j.humpath.2007.10.021. View

14.

Allred D, Harvey J, Berardo M, Clark G . Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol. 1998; 11(2):155-68. View

15.

Williams B . PKR; a sentinel kinase for cellular stress. Oncogene. 1999; 18(45):6112-20. DOI: 10.1038/sj.onc.1203127. View

16.

Chen X, Iliopoulos D, Zhang Q, Tang Q, Greenblatt M, Hatziapostolou M . XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway. Nature. 2014; 508(7494):103-107. PMC: 4105133. DOI: 10.1038/nature13119. View

17.

Bobrovnikova-Marjon E, Grigoriadou C, Pytel D, Zhang F, Ye J, Koumenis C . PERK promotes cancer cell proliferation and tumor growth by limiting oxidative DNA damage. Oncogene. 2010; 29(27):3881-95. PMC: 2900533. DOI: 10.1038/onc.2010.153. View

18.

Lu P, Jousse C, Marciniak S, Zhang Y, Novoa I, Scheuner D . Cytoprotection by pre-emptive conditional phosphorylation of translation initiation factor 2. EMBO J. 2004; 23(1):169-79. PMC: 1271668. DOI: 10.1038/sj.emboj.7600030. View

19.

Meurs E, Galabru J, Barber G, Katze M, Hovanessian A . Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase. Proc Natl Acad Sci U S A. 1993; 90(1):232-6. PMC: 45634. DOI: 10.1073/pnas.90.1.232. View

20.

Reddy K . Triple-negative breast cancers: an updated review on treatment options. Curr Oncol. 2011; 18(4):e173-9. PMC: 3149549. DOI: 10.3747/co.v18i4.738. View